BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16883320)

  • 1. Osmotic nephrosis in a renal transplant recipient.
    Ebcioglu Z; Cohen DJ; Crew RJ; Hardy MA; Ratner LE; D'Agati VD; Markowitz GS
    Kidney Int; 2006 Nov; 70(10):1873-6. PubMed ID: 16883320
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyethylstarch and osmotic nephrosis-like lesions in kidney transplants.
    Bernard C; Alain M; Simone C; Xavier M; Jean-François M
    Lancet; 1996 Dec; 348(9041):1595. PubMed ID: 8950915
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.
    Cittanova ML; Leblanc I; Legendre C; Mouquet C; Riou B; Coriat P
    Lancet; 1996 Dec; 348(9042):1620-2. PubMed ID: 8961992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes.
    Dickenmann M; Oettl T; Mihatsch MJ
    Am J Kidney Dis; 2008 Mar; 51(3):491-503. PubMed ID: 18295066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyethylstarch and renal function in kidney transplant recipients.
    Holzheimer R
    Lancet; 1997 Mar; 349(9055):883-4; author reply 884. PubMed ID: 9121292
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxyethylstarch and renal function in kidney transplant recipients.
    Coronel B; Mercatello A; Martin X; Lefrancois N
    Lancet; 1997 Mar; 349(9055):884; author reply 884. PubMed ID: 9121293
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid exacerbation of renal function after administration of hydroxyethyl starch in a dog.
    Bae J; Soliman M; Kim H; Kang S; Kim W; Ahn S; Cho K; Choi J; Kim S; Park J; Kim S; DO Y; Yoo J; Yu D
    J Vet Med Sci; 2017 Sep; 79(9):1591-1595. PubMed ID: 28867687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran removal by plasmapheresis in a kidney-pancreas transplant recipient with dextran 40-induced osmotic nephrosis.
    Bhatt AP; Neppalli VT; Kelley EA; Schlueter AJ; Thomas CP
    Am J Kidney Dis; 2011 Apr; 57(4):621-3. PubMed ID: 21257240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of osmotic nephrosis in renal tissue removed during laparoscopic nephrectomy after infusion of 6% Hydroxyethyl starch 130/0.4.
    Pinholt Kancir AS; Pleckaitis M; Ekeløf NP; Pedersen EB
    APMIS; 2015 Nov; 123(11):993-5. PubMed ID: 26495898
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of hydroxyethyl starch in critically ill patients.
    Brunkhorst FM; Schortgen F
    Br J Anaesth; 2007 Jun; 98(6):842-3; author reply 843-4. PubMed ID: 17519265
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Boldt J
    Lancet; 2001 Aug; 358(9281):581-3. PubMed ID: 11526920
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hydroxyethyl starch for volume replacement therapy - a swan song?].
    Ittner KP
    Dtsch Med Wochenschr; 2013 Nov; 138(48):2450. PubMed ID: 24254341
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Godet G
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
    [No Abstract]   [Full Text] [Related]  

  • 15. Nephrotoxicity of hydroxyethyl starch solution.
    Brunkhorst FM; Oppert M
    Br J Anaesth; 2008 Jun; 100(6):856; author reply 856-7. PubMed ID: 18483113
    [No Abstract]   [Full Text] [Related]  

  • 16. Contribution of Raman spectroscopy in nephrology: a candidate technique to detect hydroxyethyl starch of third generation in osmotic renal lesions.
    Vuiblet V; Nguyen TT; Wynckel A; Fere M; Van-Gulick L; Untereiner V; Birembaut P; Rieu P; Piot O
    Analyst; 2015 Nov; 140(21):7382-90. PubMed ID: 26413856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute kidney injury in cardiac surgery patients receiving hydroxyethyl starch solutions.
    Bayer O; Reinhart K
    Crit Care; 2015 May; 19(1):209. PubMed ID: 25940561
    [No Abstract]   [Full Text] [Related]  

  • 18. Is fluid resuscitation with high-volume hydroxyethyl starch safe for the kidney in trauma patients?
    Xue FS; Liu GP; Li RP; Sun C
    Injury; 2015 Aug; 46(8):1698-9. PubMed ID: 25823537
    [No Abstract]   [Full Text] [Related]  

  • 19. Starch solutions in Australia: the empire strikes back.
    Bellomo R
    Crit Care Resusc; 2013 Dec; 15(4):253-4. PubMed ID: 24289503
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient.
    De Labarthe A; Jacobs F; Blot F; Glotz D
    Am J Med; 2001 Oct; 111(5):417-8. PubMed ID: 11599525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.